Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Regulatory-Medicines'

Regulatory-Medicines published presentations and documents on DocSlides.

Overview of the African Medicines Regulatory
Overview of the African Medicines Regulatory
by celsa-spraggs
Harmonization and . African Medicines Agency. Mar...
Medicines Session Medicines Information Medicines
Medicines Session Medicines Information Medicines
by edwin
Basic enquiry answering. September . 2016. Session...
A n introduction to medicines development and regulation
A n introduction to medicines development and regulation
by jordyn
UKMi Horizon Scanning Working Group. Jim Glare. We...
EUROPEAN MEDICINES AGENCY
EUROPEAN MEDICINES AGENCY
by roberts
ealtEMA Regulatory Science to 2025Strategic rex006...
The Young Statistician's Guide to regulatory statistics
The Young Statistician's Guide to regulatory statistics
by dustin869
Inês Reis – Statistical assessor MHRA. PSI Care...
Generic Medicines When chemical medicines are first developed and approved, they are sold by a phar
Generic Medicines When chemical medicines are first developed and approved, they are sold by a phar
by angelina
Once . the protection of the product . expires for...
Herbal Medicines Herbal medicines are extracted from plants, or parts of plants that are thought to
Herbal Medicines Herbal medicines are extracted from plants, or parts of plants that are thought to
by stefany-barnette
Herbal preparations . could . be regarded as the ...
AIM 2030 Access to Innovative Medicines
AIM 2030 Access to Innovative Medicines
by min-jolicoeur
Draft concept for a new World Bank-led multi-stak...
PhAMA Position on Biosimilar Medicines
PhAMA Position on Biosimilar Medicines
by celsa-spraggs
Ms. Leah Goodman. Contents. Key Messages. An Over...
The Problem of Substandard Medicines in Developing Countries
The Problem of Substandard Medicines in Developing Countries
by cheryl-pisano
By Laura Christian, Linda Collins, . Maythiwan. ...
The Problem of Substandard Medicines in Developing Countries
The Problem of Substandard Medicines in Developing Countries
by pasty-toler
By Laura Christian, Linda Collins, . Maythiwan. ...
WHO Prequalification of Medicines
WHO Prequalification of Medicines
by pamella-moone
Programme. General overview and . update. Dr Mila...
Introduction to regulation of medicines and health technolo
Introduction to regulation of medicines and health technolo
by pamella-moone
Global context of drug regulation. Dr Lembit Räg...
Dr Samvel Azatyan Group Lead
Dr Samvel Azatyan Group Lead
by myesha-ticknor
Capacity Building and Harmonization Support. Regu...
IPC Meeting Agenda - 16
IPC Meeting Agenda - 16
by pasty-toler
to 17 December 2014 . World Bank, Washington DC. ...
Medicines Adaptive Pathways to Patients (MAPPs):
Medicines Adaptive Pathways to Patients (MAPPs):
by debby-jeon
Saving Time, Saving Lives. Thursday, 4 June 2015,...
Dr Samvel Azatyan Group Lead
Dr Samvel Azatyan Group Lead
by lindy-dunigan
Capacity Building and Harmonization Support. Regu...
AFRICA REGULATORY CONFERENCE FEEDBACK
AFRICA REGULATORY CONFERENCE FEEDBACK
by alexa-scheidler
DR DORCAS PETA. 1 JUNE 2012. ACKNOWLEDGEMENT. Thi...
Regulatory capacity building and NDRA approvals of prequalified
Regulatory capacity building and NDRA approvals of prequalified
by celsa-spraggs
products. Milan . Smid. . Prequalification team ...
Regulatory capacity building and NDRA approvals of prequali
Regulatory capacity building and NDRA approvals of prequali
by tatyana-admore
products. Milan . Smid. . Prequalification team ...
Barriers to access to innovative medicines
Barriers to access to innovative medicines
by ameer
Dr. Richard Torbett. Chief Economist, EFPIA. Chin...
Large scale evidence generation for the utilisation and safety of biologic medicines
Large scale evidence generation for the utilisation and safety of biologic medicines
by quinn
. Associate Professor Nicole Pratt . Quality use o...
Discharge Medicines Service (DMS) Event
Discharge Medicines Service (DMS) Event
by ceila
15 November 2022. Agenda. 7:00pm . Introduction,...
Disease Burden, Costs and Access to Valuable Cancer Medicines: 
Disease Burden, Costs and Access to Valuable Cancer Medicines: 
by osullivan
how . the pandemic has influenced the disease burd...
Pharmacy & Medicines Management
Pharmacy & Medicines Management
by madeline
2018. Objectives. Prescribing & Zero tolerance...
Introduction to Homeopathic Medicines
Introduction to Homeopathic Medicines
by anderson
V2 10/14. Disclosure:. Richard Mudd, National Phar...
Medicines Manufacturing in the UK 2017
Medicines Manufacturing in the UK 2017
by skylar
Medicines Manufacturing in the UK 2017. Welcome by...
Price Declines after Branded Medicines Lose Exclusivity in the USJan
Price Declines after Branded Medicines Lose Exclusivity in the USJan
by amey
IMS Institute for Healthcare Informatics, 100 IMS ...
Treatment Use of Unlicensed Medicines
Treatment Use of Unlicensed Medicines
by gelbero
GS K Public P ol icy Position ...
The Falsified Medicines Directive
The Falsified Medicines Directive
by TropicalParadise
The . HDA (formerly BAPW) . Who we are. Good Distr...
Medicines should help you stay healthy and live longer!
Medicines should help you stay healthy and live longer!
by CountryBumpkin
If you want to know more or are worried about your...
Getting the most out of your Arthritis medicines & your Pharmacist
Getting the most out of your Arthritis medicines & your Pharmacist
by cora
Kathy Maxwell. Community Pharmacist. Hillpark. Ca...
Taking medicines safely and effectively
Taking medicines safely and effectively
by elena
In this presentation we want to help you to know a...
WHO Essential Medicines List
WHO Essential Medicines List
by badra
Concept and Process. IPC Meeting. June 6, 2014 –...
STATISTICS ON MEDICINES
STATISTICS ON MEDICINES
by lily
kD 0A4S2UA 34A43TIKA CONSUMPTION2016x0080i tAT AH9...
Reflections on The Long Last Mile: Challenges of Access to Medicines and Comprehensive
Reflections on The Long Last Mile: Challenges of Access to Medicines and Comprehensive
by chaptoe
Case Management. George Jagoe . EVP, Access & ...
Biodiversity and Availability of Medicines
Biodiversity and Availability of Medicines
by rivernescafe
By. Isma’eel Umar Yunus. BPharm., RPh.. African ...
Short Update WHO Essential Medicines and Health products
Short Update WHO Essential Medicines and Health products
by jane-oiler
IPC Meeting . 4 to 6 . June. 2014. Essential Med...
Access to medicines and health technologies for NCDs
Access to medicines and health technologies for NCDs
by marina-yarberry
Dr Cécile . Macé. . WHO EMP , Mr Arne-Petter ....
Medicines About the team
Medicines About the team
by lois-ondreau
Claire Vaughan Head of Meds Optimisation . Lind...